On Sunday, April 20th 2025, starting 8:30am GMT, there will be maintenance work that will involve the website being unavailable during parts of the day. We apologize for any inconvenience this may cause and appreciate your understanding.
We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Evolving immune response
- Interferons
- The antiviral effect of type 1 IFN
- IFNs induce various pathways
- IFN alpha and beta in an infected cell
- Flexibility of IFN induction
- Viral infections
- Activation of immune response in viral infection (1)
- Immunoregulatory effects of type 1 IFN
- Direct antiviral vs. immunoregulatory effects of IFN
- NK cells during viral infections
- NK cells - innate lymphocytes in defense
- Regulation of NK cell responses by IFN and IL12
- Activation of immune response in viral infection (2)
- IFN signaling
- STAT1 in defense against infection
- Evidence of STAT1-independent IFN signaling
- Evidence of STAT3-independent IL-6 signaling
- Type 1 IFN signaling
- Conditioning model for regulating type 1 IFN effects
- STAT regulation mechanisms
- Cell and cytokine responses to LCMV infection
- Examining STAT expression in NK cells
- STAT expression in NK cells
- STAT expression and activation during infection
- Examining STAT responsiveness
- STAT responsiveness to type 1 IFN
- Contributing factors to STAT1 induction
- STAT1 and STAT2 in IFN gamma response
- IFN gamma expression and STAT4 activation
- Blocking IFN gamma induction
- Type 1 IFN receptor association
- Genes and proteins regulating type 1 IFN effects
- Clinical use of IFN
- Acknowledgements
Topics Covered
- Evolving immune response
- Interferons
- Antiviral effects
- IFNalfa/beta induction
- Role of IFNalfa/beta in fighting off viruses and infection
- Activation of immune response cascades during viral challenges
- Immunoregulation
- NK cells during viral infections
- Innate lymphocytes in defense
- Regulation of NK cell responses by IFNalfa/beta and IL-12
- IFN signaling
- STAT1 in defense against infection
- Kinetics of cell and cytokine responses to LCMV infections
- STAT expression in NK cells
- Type 1 IFN receptor association
- Gene expression and protein-protein interactions for regulating type 1 IFN effects
- Interferon treatment
- Interferon ablation
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Biron, C. (2009, June 30). Type I interferons in innate immunity to viral infections [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 15, 2025, from https://doi.org/10.69645/MKTL7276.Export Citation (RIS)
Publication History
- Published on June 30, 2009
Financial Disclosures
- Prof. Christine Biron has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.